glycine has been researched along with Acquired Encephalocele in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied all patients of the Glycine Antagonist (gavestinel) In Neuroprotection (GAIN) International Trial with ischemic stroke alive at day 7, excluding patients with hemorrhagic events and deaths from nonstroke-related causes." | 5.11 | Poststroke neurological improvement within 7 days is associated with subsequent deterioration. ( Aslanyan, S; Johnston, SC; Lees, KR; Weir, CJ, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aslanyan, S | 1 |
| Weir, CJ | 1 |
| Johnston, SC | 1 |
| Lees, KR | 1 |
1 trial available for glycine and Acquired Encephalocele
| Article | Year |
|---|---|
Poststroke neurological improvement within 7 days is associated with subsequent deterioration.
Topics: Aged; Aged, 80 and over; Brain Damage, Chronic; Brain Edema; Brain Ischemia; Cohort Studies; Double- | 2004 |